The Norse Eight trial was part of the data requested by the FDA after the agency rejected the BLA for the company’s Lytenava ...

Anocca has submitted its first clinical trial application (CTA) for conducting the Phase I/II VIDAR-1 trial to the EMA.

Real-world evidence (RWE) trials mainly involve observational data outside the traditional involvement of randomised ...

Aulos Bioscience has announced the first patients have been dosed as part of a trial investigating avelumab, marketed as ...

The announcement means the company will be pulling the plug on the CardinALS trial after its ALS drug failed to halt disease ...

Lexicon Pharmaceuticals has completed the enrolment of subjects for the multicentre Phase IIb PROGRESS trial of LX9211 to ...